A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
GlaxoSmithKline
Emory University
SWOG Cancer Research Network
Barbara Ann Karmanos Cancer Institute
Icahn School of Medicine at Mount Sinai
University of Iowa
University of Athens
Roswell Park Cancer Institute
Peking Union Medical College Hospital
Guangdong Provincial People's Hospital
SWOG Cancer Research Network
PETHEMA Foundation
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Northwestern University
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins